Clinical Trial Update: Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy of biphasic insulin aspart 30 in adults with type 2 diabetes not adequately controlled on oral antidiabetic drugs.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 30 (insulin aspart, biphasic 30/70)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED